StreetInsider.com News Articles

Omada Health Inc (OMDA) PT Raised to $27 at Barclays

Fri, 11 Sep 2026 05:29:55 -0400

Barclays analyst Saket Kalia raised the price target on Omada Health Inc (NASDAQ: OMDA) to $27.00 (from $25.00) while maintaining a Overweight rating.

Form 144 Omada Health, Inc. Filed by: Shao Wei-Li

Thu, 10 Sep 2026 17:18:00 -0400

si-local-file:///var/storage/secattach/20260910/27049410.html

Form 144 Omada Health, Inc. Filed by: Cook Steven L.

Thu, 10 Sep 2026 17:18:00 -0400

si-local-file:///var/storage/secattach/20260910/27049411.html

Form 144 Omada Health, Inc. Filed by: Duffy Sean P.

Thu, 10 Sep 2026 16:42:00 -0400

si-local-file:///var/storage/secattach/20260910/27049043.html

Omada Health to Present Updated Long-Term Financial Targets at Inaugural Investor Day

Thu, 10 Sep 2026 09:00:00 -0400

Omada expects to continue to grow revenue at least 20% annually, and updates long-term non-GAAP gross margin target to 80% and adjusted EBITDA margin target to 30%

SAN FRANCISCO, Sept. 10, 2026 (GLOBE NEWSWIRE) -- Omada Health (Nasdaq: OMDA), the virtual-first, between-visit healthcare provider, will present its long-term financial targets at the company's inaugural Investor Day, being held today at the Four Seasons Hotel in New York, New York.

Omada is announcing the following long-term financial targets:

Continued annual revenue growth of at least 20%
Non-GAAP gross margin of 80%
Adjusted EBITDA margin of

Omada Health to Present Updated Long-Term Financial Targets at Inaugural Investor Day

Thu, 10 Sep 2026 09:00:00 -0400

Omada expects to continue to grow revenue at least 20% annually, and updates long-term non-GAAP gross margin target to 80% and adjusted EBITDA margin target to 30%

Omada is announcing the following long-term financial targets:

Continued annual revenue growth of at least 20%
Non-GAAP gross margin of 80%
Adjusted EBITDA margin of

Form SCHEDULE 13G/A Omada Health, Inc. Filed by: Divisadero Street Capital Management, LP

Fri, 14 Aug 2026 16:36:00 -0400

si-local-file:///var/storage/secattach/20260814/26931686.html

Form SCHEDULE 13G/A Omada Health, Inc. Filed by: Divisadero Street Capital Management, LP

Fri, 14 Aug 2026 16:36:00 -0400

si-local-file:///var/storage/secattach/20260814/26931686.html

Form SCHEDULE 13G Omada Health, Inc. Filed by: AMERICAN CENTURY INVESTMENT MANAGEMENT INC

Fri, 14 Aug 2026 14:50:00 -0400

si-local-file:///var/storage/secattach/20260814/26929210.html

Form SCHEDULE 13G Omada Health, Inc. Filed by: AMERICAN CENTURY INVESTMENT MANAGEMENT INC

Fri, 14 Aug 2026 14:50:00 -0400

si-local-file:///var/storage/secattach/20260814/26929210.html

Omada Health Inc (OMDA) PT Raised to $30 at JPMorgan

Fri, 14 Aug 2026 09:04:21 -0400

JPMorgan analyst Lisa C. Gill raised the price target on Omada Health Inc (NASDAQ: OMDA) to $30.00 (from $26.00) while maintaining a Overweight rating.

Omada Health Inc (OMDA) PT Raised to $32 at Citizens on Strong Revenue Growth

Fri, 14 Aug 2026 04:15:06 -0400

Citizens analyst Constantine Davides raised the price target on Omada Health Inc (NASDAQ: OMDA) to $32.00 (from $27.00) while maintaining a Market Outperform rating.

The analyst commented, "We raise our 2026 and 2027 revenue estimates to $338M (from $328M) and $395M (from $380M), respectively. Our 2026 and 2027 EBITDA estimates move to $24.5M (from $17.0M) and $34.5M (from $22.0M), respectively. We lift our price target to $32 (5x our revised 2027 revenue estimate) from $27 (4x our prior 2027E revenue); we reaffirm our Market Outperform rating. We remain constructive on OMDA given its strong revenue growth, the continued ramp of new

Omada Health Inc (OMDA) PT Raised to $32 at Citizens on Strong Revenue Growth

Fri, 14 Aug 2026 04:15:06 -0400

Citizens analyst Constantine Davides raised the price target on Omada Health Inc (NASDAQ: OMDA) to $32.00 (from $27.00) while maintaining a Market Outperform rating.

Omada Health Inc (OMDA) PT Raised to $32 at Citizens on Strong Revenue Growth

Fri, 14 Aug 2026 04:14:53 -0400

Citizens analyst Constantine Davides raised the price target on Omada Health Inc (NASDAQ: OMDA) to $32.00 (from $27.00) while maintaining a Market Outperform rating.

Omada Health Inc (OMDA) PT Raised to $32 at Citizens on Strong Revenue Growth

Fri, 14 Aug 2026 04:14:53 -0400

Citizens analyst Constantine Davides raised the price target on Omada Health Inc (NASDAQ: OMDA) to $32.00 (from $27.00) while maintaining a Market Outperform rating.

Form 4 Omada Health, Inc. For: Aug 12 Filed by: Shao Wei-Li

Wed, 12 Aug 2026 16:50:00 -0400

si-local-file:///var/storage/secattach/20260812/26913856.html

Form 4 Omada Health, Inc. For: Aug 12 Filed by: Shao Wei-Li

Wed, 12 Aug 2026 16:50:00 -0400

si-local-file:///var/storage/secattach/20260812/26913856.html

Form 4 Omada Health, Inc. For: Aug 10 Filed by: Cook Steven L.

Wed, 12 Aug 2026 16:49:00 -0400

si-local-file:///var/storage/secattach/20260812/26913835.html

Form 4 Omada Health, Inc. For: Aug 10 Filed by: Cook Steven L.

Wed, 12 Aug 2026 16:49:00 -0400

si-local-file:///var/storage/secattach/20260812/26913835.html

Form 4 Omada Health, Inc. For: Aug 10 Filed by: Gracey Craig

Wed, 12 Aug 2026 16:47:00 -0400

si-local-file:///var/storage/secattach/20260812/26913803.html

Form 4 Omada Health, Inc. For: Aug 10 Filed by: Gracey Craig

Wed, 12 Aug 2026 16:47:00 -0400

si-local-file:///var/storage/secattach/20260812/26913803.html

Form 144 Omada Health, Inc. Filed by: Shao Wei-Li

Wed, 12 Aug 2026 16:32:00 -0400

si-local-file:///var/storage/secattach/20260812/26913528.html

Form 144 Omada Health, Inc. Filed by: Shao Wei-Li

Wed, 12 Aug 2026 16:32:00 -0400

si-local-file:///var/storage/secattach/20260812/26913528.html

Omada Health Inc (OMDA) PT Raised to $25 at Baird

Wed, 12 Aug 2026 06:19:21 -0400

Baird analyst Vikram Kesavabhotla raised the price target on Omada Health Inc (NASDAQ: OMDA) to $25.00 (from $15.00) while maintaining a Neutral rating.

Form 144 Omada Health, Inc. Filed by: Cook Steven L.

Tue, 11 Aug 2026 16:33:00 -0400

si-local-file:///var/storage/secattach/20260811/26906412.html